Pomotrelvir |
| Catalog No.GC71228 |
Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2713437-86-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Pomotrelvir (PBI-0451) is a selective, orally active SARS-CoV-2 3CL protease inhibitor. Pomotrelvir has antiviral activity and can be used in the research of novel coronavirus (COVID-19).
References:
[1]. Jessica R.Spengler, et al. Meeting report: 35th International Conference on Antiviral Research in Seattle, Washington, USA – March 21–25, 2022.
Review for Pomotrelvir
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Pomotrelvir
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *